Status:
TERMINATED
Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer
Lead Sponsor:
Royal Surrey County Hospital NHS Foundation Trust
Conditions:
Vulvar Cancer
Groin Node
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Surgery for vulvar cancer involves removal of the central tumour as well as groin node dissection as indicated depending on the stage of tumour. Groin node dissection is associated with significant co...
Detailed Description
Vulvar malignancy is the fourth most common malignancy of the female genital tract. Surgical excision achieves excellent local control and remains the mainstay of treatment. Surgical excision depends...
Eligibility Criteria
Inclusion
- To be included in this study, all women should undergo BGND during their treatment pathway for histologically confirmed vulval cancer.
- Participant is willing and able to provide informed consent.
- Aged 18 years or above.
- Participant willing to allow General Practitioner and other health care professionals, if appropriate, to be notified of participation in study.
Exclusion
- Women with vulval cancer who do not undergo BGND.
- Women with any previous groin surgery
- Women with any previous radiotherapy to the pelvic area including the groins
- Patient choice
- Women who are pregnant, lactating or planning pregnancy during the course of the study
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04105465
Start Date
July 1 2013
End Date
December 1 2016
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gynaecological Oncology, Royal Surrey County Hospital NHS Foundation Trust
Guildford, Surrey, United Kingdom, GU2 7XX